» Articles » PMID: 38389039

Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Living with HIV in the Context of Reproductive Goals in South Africa: a Qualitative Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Feb 23
PMID 38389039
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pre-exposure Prophylaxis (PrEP) and Treatment as Prevention (TasP) are effective strategies to prevent HIV transmission within serodifferent couples. However, limited usage of PrEP, knowledge and interest has been amongst the barriers for men, alongside testing and treatment adherence. We explored the perceptions of PreP for HIV prevention with Men living with HIV (MWH) who have reproductive goals, to understand awareness and experiences related to PrEP use in the context of HIV prevention with their partners.

Methods: We undertook a qualitative study with 25 MWH aged 18 to 65 between April and September 2021 in South Africa. Potential participants were screened for eligibility and scheduled to participate in telephonic interviews. Interviews were audio recorded, transcribed, translated and thematically analysed.

Results: Themes were organized into opportunities and barriers that men with HIV articulate as important for using PrEP to meet individual, couple, and community reproductive goals. At the individual level, some men were willing to discuss PrEP with their partners to protect their partners and babies from acquiring HIV. Lack of knowledge about PrEP among men was a potential barrier to promoting PrEP among their female partners. At the couple level, PrEP use was seen as a way to strengthen relationships between partners, signifying care, trust, and protection and was seen as a tool to help serodifferent couples meet their reproductive goals safely. At the community level, PrEP was viewed as a tool to promote HIV testing and prevention efforts, especially among men, but participants emphasized the need for more education and awareness.

Conclusion: Despite PrEP implementation in South Africa, awareness of PrEP among men with HIV in rural areas remains low. Engaging MWH to support their partners in accessing PrEP could be an innovative strategy to promote HIV prevention. Additionally, providing men with comprehensive reproductive health information can empower them to make more informed decisions, adopt safer sexual practices, and challenge societal norms and stigmas around HIV.

Citing Articles

PrEP Awareness and Coverage: Results from the 2022 South Africa Antenatal HIV Sentinel Survey.

Shangase N, Kufa T, Cheyip M, Puren A AIDS Behav. 2025; .

PMID: 39939480 DOI: 10.1007/s10461-024-04609-3.


Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa.

Matthews L, Jaggernath M, Kriel Y, Smith P, Haberer J, Baeten J AIDS. 2024; 38(9):1342-1354.

PMID: 38752557 PMC: 11211057. DOI: 10.1097/QAD.0000000000003925.

References
1.
Oldenburg C, Barnighausen T, Tanser F, Iwuji C, de Gruttola V, Seage 3rd G . Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa. Clin Infect Dis. 2016; 63(4):548-54. PMC: 4967606. DOI: 10.1093/cid/ciw335. View

2.
van Vliet M, Hendrickson C, Nichols B, Boucher C, Peters R, van de Vijver D . Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. J Int AIDS Soc. 2019; 22(12):e25427. PMC: 6922023. DOI: 10.1002/jia2.25427. View

3.
Davies N, Matthews L, Crankshaw T, Cooper D, Schwartz S . Supporting HIV prevention and reproductive goals in an HIV-endemic setting: taking safer conception services from policy to practice in South Africa. J Int AIDS Soc. 2017; 20(Suppl 1):21271. PMC: 5577693. DOI: 10.7448/IAS.20.2.21271. View

4.
Sack D, De Schacht C, Paulo P, Graves E, Emilio A, Matino A . Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique. Glob Health Action. 2021; 14(1):1940764. PMC: 8266225. DOI: 10.1080/16549716.2021.1940764. View

5.
Baeten J, Palanee-Phillips T, Brown E, Schwartz K, Soto-Torres L, Govender V . Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016; 375(22):2121-2132. PMC: 4993693. DOI: 10.1056/NEJMoa1506110. View